Skip to main content
Equibles

LETKO, BROSSEAU & ASSOCIATES INC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1297496 MONTREAL, A8
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$93,957
-$2,876 QoQ
Shares Held
95,875
0.0% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 60 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LETKO, BROSSEAU & ASSOCIATES INC holds $55,170,971 across 18 Biotechnology names. TCRX ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 724,830 $50,759,844
2 PVLA
Palvella Therapeutics, Inc.
 3,500 $534,870
3 ELVN
Enliven Therapeutics, Inc.
 9,600 $487,200
4 MGTX
MeiraGTx Holdings plc
 32,000 $432,320
5 GHRS
GH Research PLC
 15,425 $414,624
6 BCAX
Bicara Therapeutics Inc.
 11,175 $331,785
7 NAMS
NewAmsterdam Pharma Co N.V.
 9,475 $321,107
8 SPRY
ARS Pharmaceuticals, Inc.
 40,050 $320,800

All Filings in TCRX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,957 95,875
2026-03-31 $96,833 95,875
2025-12-31 $95,875 95,875
2025-09-30 $174,492 95,875
2025-06-30 $139,018 95,875
2025-03-31 $106,398 77,100
2024-12-31 $110,048 36,200
2024-09-30 $103,086 20,700
2024-06-30 $121,095 20,700
2024-03-31 $164,358 20,700
2023-12-31 $120,681 20,700
2023-09-30 $82,944 32,400